Annals of the American Thoracic Society is a premier journal dedicated to advancing the field of pulmonary and respiratory medicine. Published by the American Thoracic Society, this journal offers an invaluable platform for researchers and clinicians to disseminate cutting-edge research, clinical insights, and innovative methodologies. With an impressive impact factor and ranked in the top Q1 category of its field (2023) and within the top 20 of 155 according to Scopus rankings, it is positioned as a leading force in shaping clinical practice and research directions. The journal's convergence years from 2013 to 2024 indicate a commitment to providing timely and relevant content at the forefront of pulmonary health. While not an open-access journal, it ensures broad accessibility to its significant contributions in respiratory medicine, making it an essential resource for professionals, researchers, and students alike endeavoring to deepen their understanding and improve outcomes in thoracic health.

TOBACCO CONTROL is a leading journal published by the BMJ Publishing Group, dedicated to advancing the field of public health, especially concerning tobacco usage and its multifaceted impacts on society. With an ISSN of 0964-4563 and E-ISSN of 1468-3318, this journal offers unparalleled insights into tobacco control policy, epidemiology, and behavioral studies, fostering a platform for research that can significantly influence public health strategies worldwide. Recognized with a Q1 ranking in the fields of Health (social science) and Public Health, Environmental and Occupational Health for 2023, TOBACCO CONTROL holds a prestigious position among the top journals in its domain, with an impressive Scopus rank of #17 out of 371 in Health (social science) and #48 out of 665 in Public Health. Through its commitment to rigorous peer review and high-quality research articles, the journal aims to disseminate knowledge that can combat the tobacco epidemic, ultimately contributing to improved health outcomes. Although not open access, the journal's dedicated focus on illuminating effective tobacco control measures makes it an essential resource for researchers, policymakers, and health professionals alike.

Clinical Epidemiology and Global Health, published by Elsevier - Division Reed Elsevier India Pvt Ltd, is a leading open-access journal dedicated to the dissemination of research in the crucial fields of epidemiology and global health. With an ISSN of 2452-0918 and an E-ISSN of 2213-3984, this journal has been a platform for innovative studies since its inception in 2013, converging into a comprehensive resource through 2024. Operating from the Netherlands and ensuring accessibility from anywhere in the world since its transition to an open-access model in 2021, it fosters the global exchange of knowledge. The journal's impact is reflected in its current quartile rankings, including Q2 in Public Health, Environmental and Occupational Health and Q3 in Epidemiology, Infectious Diseases, and Microbiology. With a growing reputation bolstered by SCOPUS rankings that place it in the top percentiles, Clinical Epidemiology and Global Health stands as an essential resource for researchers, professionals, and students dedicated to advancing public health and epidemiological research.

Tobacco Prevention & Cessation is a vital open-access journal published by EUROPEAN PUBLISHING, dedicated to advancing knowledge in the fields of public health and tobacco control. Established in 2015, this journal provides a platform for the dissemination of high-quality research aimed at reducing tobacco use and improving cessation strategies worldwide. With an impressive impact across various categories, including a Q1 ranking in Health Professions, the journal is integral to the global health community, highlighting critical issues related to tobacco prevention and cessation practices. Researchers and practitioners can benefit from access to cutting-edge studies designed to inform policies and practices, making this journal an essential resource for those committed to combating tobacco-related health challenges. Operating under an open-access model, Tobacco Prevention & Cessation ensures that impactful research is available to all, furthering its mission of fostering public health education and awareness.

DRUG AND ALCOHOL REVIEW, published by Wiley, is a leading journal dedicated to advancing the scholarship in the fields of drug and alcohol research. Since its inception in 1989, this esteemed publication has provided a critical platform for the dissemination of innovative research findings, reviews, and theoretical papers, addressing pressing issues in substance use and addiction. With an impact factor that places it in the Q1 category in both Health (social science) and Medicine (miscellaneous), it ranks #78 out of 371 in the Scopus index for Health and #115 out of 398 in Medicine, reflecting its significant influence and high citation rates among scholars. The journal is committed to fostering a multidisciplinary approach, integrating perspectives from psychology, sociology, public health, and medicine, to inform policy and practice. Accessible to researchers and practitioners alike, *DRUG AND ALCOHOL REVIEW* serves as an essential resource for anyone invested in understanding and addressing the complexities of drug and alcohol use in society.

Environmental Health Perspectives (EHP) is a premier open-access journal published by the U.S. Department of Health and Human Services, Public Health Science, dedicated to publishing rigorous and impactful research in the field of environmental health. Since its inception in 1972, EHP has become a leading platform for disseminating knowledge on the interactions between the environment and human health, making significant contributions to the fields of toxicology and public health. With an impressive impact factor and a Q1 ranking in both Health, Toxicology and Mutagenesis and Public Health, Environmental and Occupational Health categories, EHP ranks among the top journals globally, reflecting its high citation and visibility within the academic community. Researchers, professionals, and students alike will find a wealth of vital information within its pages, as EHP covers a wide array of topics related to environmental exposures, health outcomes, and policy implications. Furthermore, EHP engages with a global audience through its commitment to open access, ensuring that critical research is available to all, enhancing the collective understanding of environmental health issues since 1972.

Welcome to Epidemiology and Health, a premier open-access journal dedicated to advancing knowledge in the fields of epidemiology and public health. Published by the Korean Society of Epidemiology since 1979, this journal serves as a vital platform for researchers, professionals, and students alike, promoting innovative research and robust discussion surrounding public health issues. Based in South Korea, it boasts a commendable Q2 ranking in the categories of Epidemiology, Public Health, and Environmental and Occupational Health, reflecting its significant contribution to the scientific community. With its current impact factor ranking it favorably among peers—#124 out of 665 in Public Health and #40 out of 148 in Epidemiology—Epidemiology and Health continues to uphold its mission of disseminating high-quality, peer-reviewed research. The journal's commitment to open access ensures that vital epidemiological insights reach a broad audience, supporting the collective goal of improving global health outcomes. Engage with pioneering studies and emerging trends within these critical fields, as we work towards a healthier future.

NICOTINE & TOBACCO RESEARCH, published by Oxford University Press, is a leading journal dedicated to advancing the understanding of nicotine and tobacco-related issues through rigorous research and analysis. Established in 1999, this esteemed journal has become a critical resource for scholars and practitioners in the fields of public health, environmental, and occupational health, maintaining a prestigious Q1 classification in its category as of 2023. With an impressive ranking of 67 out of 665 in the Scopus database, placing it in the 90th percentile, it is recognized for its high-quality contributions that resonate with current global health challenges. Although open access options are not available, the journal’s articles are accessible to a broad audience, ensuring that cutting-edge research reaches those who need it most. As it looks toward 2024 and beyond, NICOTINE & TOBACCO RESEARCH remains committed to promoting innovative research that informs policies and practices aimed at reducing tobacco use and its associated harms, thus playing a pivotal role in enhancing public health worldwide.

Addicta - The Turkish Journal on Addictions, published by the esteemed Turkish Green Crescent Society, is an open access journal dedicated to advancing the understanding of addictions and their implications on mental health. Since its inception in 2019, this journal has become a significant platform for interdisciplinary research, focusing on the biological, psychological, and sociocultural aspects of addiction. With a focus on both empirical studies and theoretical discussions, Addicta seeks to foster a greater understanding of addiction as a complex phenomenon, facilitating knowledge sharing among researchers, practitioners, and policymakers. The journal has achieved notable rankings, residing in the Q4 category in Biological Psychiatry and Psychiatry and Mental Health, and Q3 in miscellaneous Psychology, marking its growing impact in the field. Accessing its content is completely free, making important research accessible to a broader audience. Based in Turkey, Addicta provides a vital resource for those interested in the nuances of addiction research, promoting innovative solutions and fostering collaboration across disciplines.

The AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY, published by the esteemed American Thoracic Society, is a premier platform dedicated to advancing knowledge in the fields of pulmonary and respiratory medicine, cell biology, and clinical biochemistry. With an impressive impact factor and recognition as a Q1 journal in multiple categories for 2023, it ranks among the top tier of scholarly publications, evidencing its influence and contribution to the scientific community. Since its inception in 1989, the journal has provided a critical forum for researchers and professionals to disseminate innovative findings and pivotal reviews, driving forward the frontiers of respiratory biology. While the journal currently operates under traditional access mechanisms, it seeks to bridge gaps in research by presenting high-quality articles that address vital health challenges. As a key resource for both established researchers and emerging scholars in molecular biology and respiratory science, this journal plays a pivotal role in shaping the future of respiratory health advancements.